The Chemotherapy Compounding Payments Scheme (CCPS) ensures that all Australians who require chemotherapy have access to these anti-cancer drugs.

AHA manages the scheme on behalf of the department, operating as the CCPS Administration Agency.

Chemotherapy medicine infusions are more complex to dispense than standard medicines because:

• many are highly toxic
• doses vary according to patient size or treatment requirement
• doses must usually be compounded in sterile conditions shortly before the infusion is administered.

Compounders registered under the CCPS receive a fee for each PBS dose compounded into a chemotherapy infusion.

AHA developed a custom online system to streamline claims processing. We also host the CCPS website and provide support and advice about the scheme.

Each year, we disburse around $15 million of funds to TGA-licensed compounders under the scheme. Our processes are underpinned by rigorous monitoring of compliance and regular reports to the department.